×
About 3,218 results

ALLMedicine™ Allergic Contact Dermatitis Center

Research & Reviews  1,019 results

Comparison between patch test results of natural dyes and standard allergens in batik w...
https://doi.org/10.1080/15569527.2022.2077751
Cutaneous and Ocular Toxicology; Diana EDN, Widhiati S et. al.

Jul 1st, 2022 - Occupational contact dermatitis (OCD) is a skin disorder caused by contact with any substances found in the workplace. Occupational contact dermatitis is second most common occupational disease (15% of all cases of occupational disease). Occupatio...

Precious Contactants: A Case of Professional Allergic Contact Dermatitis in a Jeweler.
https://doi.org/10.1097/DER.0000000000000917
Dermatitis : Contact, Atopic, Occupational, Drug; Baeza-Hernández G, Rubio-Aguilera RF et. al.

Jun 30th, 2022 - Precious Contactants: A Case of Professional Allergic Contact Dermatitis in a Jeweler.|2022|Baeza-Hernández G,Rubio-Aguilera RF,Esteban-Garrido E,Vallejo-Ruiz MS,Guerrero-Torija A,|

Black-Spot Toxicodendron Dermatitis With Varied Presentation.
https://doi.org/10.1016/j.wem.2022.05.002
Wilderness & Environmental Medicine; Rabinovich EP, Barquin JN et. al.

Jun 20th, 2022 - This article describes the clinical presentation, differential diagnosis, and treatment of 2 unrelated cases with different presentations of black-spot Toxicodendron dermatitis. In the first case, a healthy 7-y-old male presented with a rash consi...

Dyshidrotic Eczema (Pompholyx)
https://emedicine.medscape.com/article/1122527-overview

Jun 20th, 2022 - Practice Essentials Dyshidrotic eczema, also termed pompholyx, is a type of eczema (dermatitis). This skin condition is characterized by intensely itchy blisters that develop on the edges of the fingers, toes, palms, and soles of the feet. Dyshidr...

Dyshidrotic Eczema (Pompholyx)
http://emedicine.medscape.com/article/1122527-overview

Jun 20th, 2022 - Practice Essentials Dyshidrotic eczema, also termed pompholyx, is a type of eczema (dermatitis). This skin condition is characterized by intensely itchy blisters that develop on the edges of the fingers, toes, palms, and soles of the feet. Dyshidr...

see more →

Guidelines  2 results

Typical Contact Dermatitis Screening Misses Many Allergens
https://www.medscape.com/viewarticle/962856
Medscape Frellick M.

Nov 12th, 2021 - Standard patch test screening, which tests for up to 70 allergens for patients with allergic contact dermatitis, is limited and may miss many allergens, a study published in JAMA Dermatology has found. Dr Erin M. Warshaw The cross-sectiona...

EAACI position paper for practical patch testing in allergic contact dermatitis in chil...
https://doi.org/10.1111/pai.12463
Pediatric Allergy and Immunology : Official Publication O... de Waard-van der Spek FB, Darsow U et. al.

Aug 20th, 2015 - Allergic contact dermatitis (ACD) in children appears to be on the increase, and contact sensitization may already begin in infancy. The diagnosis of contact dermatitis requires a careful evaluation of a patient's clinical history, physical examin...

see more →

Drugs  25 results see all →

Clinicaltrials.gov  28 results

Allergy Skin Patch Artificial Intelligence (AI)
https://clinicaltrials.gov/ct2/show/NCT05339750

Apr 21st, 2022 - Study participation involves three visits to the study site on Days 1, 3, and 5, and completion of a demographics and allergy history questionnaire. Researchers will review medical history and current medications. On Day 1 a patch will be applied ...

Evaluation of EB01 Cream for the Treatment of Chronic Allergic Contact Dermatitis
https://clinicaltrials.gov/ct2/show/NCT03680131

Apr 1st, 2022 - The purpose of this study is to evaluate the safety and efficacy of EB01 Cream (0.2%, 1.0%, 2.0%) applied twice per day (BID) for the treatment of moderate to severe chronic allergic contact dermatitis (ACD). The purpose of the open label extensio...

Efficacy of Baricitinib In Treatment of Delayed-Type Hypersensitivity Versus Irritant Skin Reactions in Healthy Adult Male Subjects
https://clinicaltrials.gov/ct2/show/NCT03945760

Jan 28th, 2022 - The treatment of allergic contact dermatitis (ACD) can be unsatisfactory, and that other skin diseases such as atopic dermatitis have an increased likelihood of ACD, improved systemic treatments are needed. This research study explores the effecti...

Study of the Intradermal Injection of rHuPH20 or Placebo in Participants With Nickel Allergic Contact Dermatitis
https://clinicaltrials.gov/ct2/show/NCT00928447

Dec 17th, 2021 - This study will involve 2 regimens which will run in parallel. Each participant's upper back will be divided into 2 equal spaces for Regimen 1 and 2. Each of the 4 treatment sites in each space will be independently randomized to placebo or rHuPH2...

Typical Contact Dermatitis Screening Misses Many Allergens
https://www.medscape.com/viewarticle/962856
Medscape Frellick M.

Nov 12th, 2021 - Standard patch test screening, which tests for up to 70 allergens for patients with allergic contact dermatitis, is limited and may miss many allergens, a study published in JAMA Dermatology has found. Dr Erin M. Warshaw The cross-sectiona...

see more →

News  210 results

Dupilumab for Allergic Contact Dermatitis: An Overview of Its Use and Impact on Patch Testing
https://www.mdedge.com/dermatology/article/254687/contact-dermatitis/dupilumab-allergic-contact-dermatitis-overview-its-use
Hadley Johnson, BS, Brandon L. Adler, MD et. al.

May 17th, 2022 - Dupilumab is a humanized monoclonal antibody approved by the US Food and Drug Administration (FDA) for the treatment of moderate to severe atopic dermatitis. Through inhibition of the IL-4R α subunit, it prevents activation of the IL-4/IL-13 signa.

Hidden Formaldehyde in Products Linked to Allergic Reactions
https://www.medscape.com/viewarticle/971390

Mar 31st, 2022 - Hidden formaldehyde and formaldehyde releasers found in many cosmetics and other products, including personal protective equipment to shield healthcare workers from COVID-19, provoke allergic reactions in some people, report the authors of a clini...

Patch Testing on Dupilumab: Reliable or Not?
https://www.mdedge.com/dermatology/article/252376/contact-dermatitis/patch-testing-dupilumab-reliable-or-not
Alexandra Kuzyk, MD, PhD, Alim R. Devani, MD et. al.

Mar 3rd, 2022 - In patients with persistent atopic dermatitis (AD) who are taking dupilumab, is there benefit of patch testing to determine if allergic contact dermatitis (ACD) also is contributing to their disease? Results of patch testing are likely be influenc.

Derms in survey say climate change is impacting their patients
https://www.mdedge.com/dermatology/article/251759/mixed-topics/derms-survey-say-climate-change-impacting-their-patients
Christine Kilgore

Feb 14th, 2022 - Global climate change is hitting home for dermatologists, according to a recent survey in which the majority of participants said their patients are already being impacted. Almost 80% of the 148 participants who responded to an electronic survey r.

Contact Allergy to Topical Medicaments, Part 2: Steroids, Immunomodulators, and Anesthetics, Oh My!
https://www.mdedge.com/dermatology/article/250562/contact-dermatitis/contact-allergy-topical-medicaments-part-2-steroids
Ashley Ng, BS, Amber Reck Atwater, MD et. al.

Jan 10th, 2022 - In the first part of this 2-part series (Cutis. 2021;108:271-275), we discussed topical medicament allergic contact dermatitis (ACD) from acne and rosacea medications, antimicrobials, antihistamines, and topical pain preparations.

see more →

Patient Education  3 results see all →